Akihiro Tanaka
Toyama, 9300194, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 71 publications
Reduced versus standard dosing of Janus kinase inhibitors in rheumatoid arthritis: a propensity score-matched real-world study accounting for poor prognostic factors.
Journal: Annals of the rheumatic diseases
Published: February 08, 2026
Non-canonical Activation of RSK1 Induces EphA2-Mediated Cell Migration under Cellular Stress Conditions.
Journal: Biological & pharmaceutical bulletin
Published: July 28, 2025
Stress Response Kinase MK2 Induces Non-canonical Activation of EphA2 in EML4-ALK Lung Cancer Cells.
Journal: Biological & pharmaceutical bulletin
Published: March 02, 2025
Sustained efficacy of second-line JAK inhibitors in patients with rheumatoid arthritis: insights from the ANSWER cohort.
Journal: Rheumatology (Oxford, England)
Published: November 15, 2024
Circulating CD31 and resistin levels reflect different stages of coronary atherosclerosis in patients with psoriasis.
Journal: The Journal of dermatology
Published: March 25, 2024
Cooperative function of oncogenic MAPK signaling and the loss of Pten for melanoma migration through the formation of lamellipodia.
Journal: Scientific reports
Published: May 02, 2023
The Correlation between the Vascular Calcification Score of the Coronary Artery and the Abdominal Aorta in Patients with Psoriasis.
Journal: Diagnostics (Basel, Switzerland)
Published: December 01, 2022
Cellular stress induces non-canonical activation of the receptor tyrosine kinase EphA2 through the p38-MK2-RSK signaling pathway.
Journal: The Journal of biological chemistry
Published: September 28, 2022
Long-Term Outcomes and Clinical Predictors of Mortality Following Occurrence of Stent Thrombosis.
Journal: Journal of the American Heart Association
Published: April 04, 2022
Suitable Dose of Long-Term Tolvaptan to Reduce Heart Failure Rehospitalizations.
Journal: International heart journal
Published: January 31, 2022
Temporal Change in Renoprotective Effect of Tolvaptan on Patients with Heart Failure: AURORA Study.
Journal: Journal of clinical medicine
Published: January 06, 2022
Underweight Is Associated with Poor Prognosis in Heart Failure with Preserved Ejection Fraction.
Journal: International heart journal
Published: September 21, 2021
Last Updated: 09/26/2026